AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Diphtheria Toxoid
8 registrations across 3 African markets— 6 active
Markets with Diphtheria Toxoid
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DIFTAVAX | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| PENTAXIM ( DIPHTHERI A,TETANUS, PERTUSSIS (ACELLULA R, COMPONEN T),POLIOMY ELITIS (INACTIVAT ED) VACCINE AND HAEMOPHI LUS TYPE B CONJUGAT E VACCINE) 0.5ML (1 SYRINGE + 1 VIAL) | 🇳🇬Nigeria | SANOFI AVENSIS NIGERIA LTD PLOT 8 DR NURUDEEN OLOWOPOPO AVENUE | expired | Apr 2021 |
| INFANRIX HEXA | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| TETRAXIM | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| HEXAXIM | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| BOOSTRIX TETRA | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| ADACEL QUADRA | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| Vaxtar-5 suspension vaccine | 🇹🇿Tanzania | INDIAN IMMUNOLOGICAL LIMITED | active | — |
Diphtheria Toxoid in Africa — Regulatory Overview
Diphtheria Toxoid is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Nigeria, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 6 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.